198 related articles for article (PubMed ID: 38349785)
21. SOX10 Expression as Well as BRAF and GNAQ/11 Mutations Distinguish Pigmented Ciliary Epithelium Neoplasms From Uveal Melanomas.
Mori T; Sukeda A; Sekine S; Shibata S; Ryo E; Okano H; Suzuki S; Hiraoka N
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5445-5451. PubMed ID: 29059311
[TBL] [Abstract][Full Text] [Related]
22. Current molecular and clinical insights into uveal melanoma (Review).
Fallico M; Raciti G; Longo A; Reibaldi M; Bonfiglio V; Russo A; Caltabiano R; Gattuso G; Falzone L; Avitabile T
Int J Oncol; 2021 Apr; 58(4):. PubMed ID: 33649778
[TBL] [Abstract][Full Text] [Related]
23. Genetic and clinico-pathologic analysis of metastatic uveal melanoma.
Griewank KG; van de Nes J; Schilling B; Moll I; Sucker A; Kakavand H; Haydu LE; Asher M; Zimmer L; Hillen U; Thompson JF; Scolyer RA; Schadendorf D; Murali R
Mod Pathol; 2014 Feb; 27(2):175-83. PubMed ID: 23887304
[TBL] [Abstract][Full Text] [Related]
24. Transposase mapping identifies the genomic targets of BAP1 in uveal melanoma.
Yen M; Qi Z; Chen X; Cooper JA; Mitra RD; Onken MD
BMC Med Genomics; 2018 Nov; 11(1):97. PubMed ID: 30400891
[TBL] [Abstract][Full Text] [Related]
25. Effects of Long-term Serial Passaging on the Characteristics and Properties of Cell Lines Derived From Uveal Melanoma Primary Tumors.
Mouriaux F; Zaniolo K; Bergeron MA; Weidmann C; De La Fouchardière A; Fournier F; Droit A; Morcos MW; Landreville S; Guérin SL
Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5288-5301. PubMed ID: 27723895
[TBL] [Abstract][Full Text] [Related]
26. A Subset of Nuclear Receptors are Uniquely Expressed in Uveal Melanoma Cells.
Huffman KE; Carstens R; Martinez ED
Front Endocrinol (Lausanne); 2015; 6():93. PubMed ID: 26217306
[TBL] [Abstract][Full Text] [Related]
27. Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma.
Ewens KG; Kanetsky PA; Richards-Yutz J; Purrazzella J; Shields CL; Ganguly T; Ganguly A
Invest Ophthalmol Vis Sci; 2014 Jun; 55(8):5160-7. PubMed ID: 24970262
[TBL] [Abstract][Full Text] [Related]
28. Metastatic Disease in Polyploid Uveal Melanoma Patients Is Associated With BAP1 Mutations.
Yavuzyigitoglu S; Mensink HW; Smit KN; Vaarwater J; Verdijk RM; Beverloo B; Brüggenwirth HT; van Marion R; Dubbink HJ; Paridaens D; Naus NC; de Klein A; Kiliç E;
Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):2232-9. PubMed ID: 27116551
[TBL] [Abstract][Full Text] [Related]
29. In uveal melanoma Gα-protein GNA11 mutations convey a shorter disease-specific survival and are more strongly associated with loss of BAP1 and chromosomal alterations than Gα-protein GNAQ mutations.
Piaggio F; Croce M; Reggiani F; Monti P; Bernardi C; Ambrosio M; Banelli B; Dogrusöz M; Jockers R; Bordo D; Puzone R; Viaggi S; Coviello D; Lanza FB; Bartolucci M; Petretto A; Mosci C; Gangemi R; van der Velden PA; Jager MJ; Pfeffer U; Amaro A
Eur J Cancer; 2022 Jul; 170():27-41. PubMed ID: 35580369
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive Genetic Landscape of Uveal Melanoma by Whole-Genome Sequencing.
Royer-Bertrand B; Torsello M; Rimoldi D; El Zaoui I; Cisarova K; Pescini-Gobert R; Raynaud F; Zografos L; Schalenbourg A; Speiser D; Nicolas M; Vallat L; Klein R; Leyvraz S; Ciriello G; Riggi N; Moulin AP; Rivolta C
Am J Hum Genet; 2016 Nov; 99(5):1190-1198. PubMed ID: 27745836
[TBL] [Abstract][Full Text] [Related]
31. [Extraction and isolation of histones from paraffin-embedded tissues and quantitative analysis of post-translational modifications].
Tian S; Liu R; Qian X; Guo X; Zhang K
Se Pu; 2021 Oct; 39(10):1094-1101. PubMed ID: 34505431
[TBL] [Abstract][Full Text] [Related]
32. Genomic Profiling of Metastatic Uveal Melanoma Shows Frequent Coexisting BAP1 or SF3B1 and GNAQ/GNA11 Mutations and Correlation With Prognosis.
Isaacson AL; Sompallae RR; Guseva NV; Bellizzi AM; Bossler AD; Ma D
Am J Clin Pathol; 2022 Aug; 158(2):177-186. PubMed ID: 35212356
[TBL] [Abstract][Full Text] [Related]
33. Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes.
Decatur CL; Ong E; Garg N; Anbunathan H; Bowcock AM; Field MG; Harbour JW
JAMA Ophthalmol; 2016 Jul; 134(7):728-33. PubMed ID: 27123562
[TBL] [Abstract][Full Text] [Related]
34. Status of RASSF1A in uveal melanocytes and melanoma cells.
Calipel A; Abonnet V; Nicole O; Mascarelli F; Coupland SE; Damato B; Mouriaux F
Mol Cancer Res; 2011 Sep; 9(9):1187-98. PubMed ID: 21788308
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma.
Patrone S; Maric I; Rutigliani M; Lanza F; Puntoni M; Banelli B; Rancati S; Angelini G; Amaro A; Ligorio P; Defferrari C; Castagnetta M; Bandelloni R; Mosci C; DeCensi A; Romani M; Pfeffer U; Viaggi S; Coviello DA
Genes Chromosomes Cancer; 2018 Aug; 57(8):387-400. PubMed ID: 29689622
[TBL] [Abstract][Full Text] [Related]
36. An insight into the molecular genetics of a uveal melanoma patient cohort.
Kennedy S; Rice M; Toomey S; Horgan N; Hennessey BT; Larkin A
J Cancer Res Clin Oncol; 2018 Oct; 144(10):1861-1868. PubMed ID: 30008023
[TBL] [Abstract][Full Text] [Related]
37. Genetic and epigenetic insights into uveal melanoma.
Sharma A; Stei MM; Fröhlich H; Holz FG; Loeffler KU; Herwig-Carl MC
Clin Genet; 2018 May; 93(5):952-961. PubMed ID: 28902406
[TBL] [Abstract][Full Text] [Related]
38. Targeted Next-Generation Sequencing of 117 Routine Clinical Samples Provides Further Insights into the Molecular Landscape of Uveal Melanoma.
Thornton S; Coupland SE; Olohan L; Sibbring JS; Kenny JG; Hertz-Fowler C; Liu X; Haldenby S; Heimann H; Hussain R; Kipling N; Taktak A; Kalirai H
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32340176
[TBL] [Abstract][Full Text] [Related]
39. The AMP-dependent kinase pathway is upregulated in BAP1 mutant uveal melanoma.
Chua V; Han A; Bechtel N; Purwin TJ; Hunter E; Liao C; Harbour JW; Aplin AE
Pigment Cell Melanoma Res; 2022 Jan; 35(1):78-87. PubMed ID: 34347929
[TBL] [Abstract][Full Text] [Related]
40. BAP1 mutant uveal melanoma is stratified by metabolic phenotypes with distinct vulnerability to metabolic inhibitors.
Han A; Purwin TJ; Bechtel N; Liao C; Chua V; Seifert E; Sato T; Schug ZT; Speicher DW; Harbour JW; Aplin AE
Oncogene; 2021 Jan; 40(3):618-632. PubMed ID: 33208912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
